会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 23. 发明授权
    • 4-Hydroxy-2H-naphtho[2,1-e]-1,2-thiazine-3-carboxamide-1,1-dioxides and
salts thereof
    • 4-羟基-2H-萘并({2,1-e {9-1,2-噻嗪-3-甲酰胺-1,1-二氧化物及其盐
    • US3992535A
    • 1976-11-16
    • US626623
    • 1975-10-29
    • Gunter TrummlitzHelmut TeufelWolfhard EngelErnst SeegerWalter HaarmannGunther Engelhardt
    • Gunter TrummlitzHelmut TeufelWolfhard EngelErnst SeegerWalter HaarmannGunther Engelhardt
    • C07D275/06C07D279/02C07D417/12C07D513/04A61K31/54
    • C07D275/06C07D279/02
    • Compounds of the formula ##SPC1##WhereinR.sub.1 is hydrogen, methyl or ethyl, andAr is phenyl, 3-chlorophenyl, 3-bromophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 3-tolyl, 2-methoxyphenyl, 3-methoxyphenyl, 2-pyridyl, 4-methyl-2-pyridyl, 6-methyl-2-pyridyl, 3-hydroxy-2-pyridyl, 3-pyridyl, 4-pyridyl, 6-chloro-3-pyridazinyl, 2-pyrazinyl, 6-chloro-2-pyrazinyl, 6-chloro-4-pyrimidinyl, 2-thiazolyl, 4-methyl-2-thiazolyl, 4-ethyl-2-thiazolyl, 5-methyl-2-thiazolyl, 5-ethyl-2-thiazolyl, 4,5-dimethyl-2-thiazolyl, 4-ethyl-5-methyl-2-thiazolyl, 5-ethyl-4-methyl-2-thiazolyl, 2-benzothiazolyl, 4,5,6,7-tetrahydro-2-benzothiazolyl, 5,6-dihydro-7H-thiopyrano[4,3-d]thiazol-2-yl, 3-methyl-5-isothiazolyl, 1,3,4-thiadiazolyl, 5-methyl-1,3,4-thiadiazol-2-yl or 5-methyl-3-isoxazolyl,And non-toxic, pharmacologically acceptable salts thereof formed with an inorganic or organic base; the compounds as well as their salts are useful as inhibitors of platelet adhesion and aggregation.
    • 式WHERE R1的化合物是氢,甲基或乙基,Ar是苯基,3-氯苯基,3-溴苯基,2-氟苯基,3-氟苯基,4-氟苯基,3-甲苯基,2-甲氧基苯基,3-甲氧基苯基, 2-吡啶基,4-甲基-2-吡啶基,6-甲基-2-吡啶基,3-羟基-2-吡啶基,3-吡啶基,4-吡啶基,6-氯-3-哒嗪基,2-吡嗪基,6-吡啶基, 4-氯-2-吡嗪基,6-氯-4-嘧啶基,2-噻唑基,4-甲基-2-噻唑基,4-乙基-2-噻唑基,5-甲基-2-噻唑基,5-乙基-2-噻唑基, 4,5-二甲基-2-噻唑基,4-乙基-5-甲基-2-噻唑基,5-乙基-4-甲基-2-噻唑基,2-苯并噻唑基,4,5,6,7-四氢-2- 苯并噻唑基,5,6-二氢-7H-噻喃并[4,3-d]噻唑-2-基,3-甲基-5-异噻唑基,1,3,4-噻二唑基,5-甲基-1,3,4-噻二唑基, 噻二唑-2-基或5-甲基-3-异恶唑基,以及与无机或有机碱形成的非毒性,药理学上可接受的盐; 化合物作为它们的盐作为板材粘合和聚集的抑制剂有用。
    • 27. 发明授权
    • Paper stacking apparatus for office machines
    • 办公机械用纸堆叠装置
    • US4995747A
    • 1991-02-26
    • US230472
    • 1988-08-09
    • Gunther EngelhardtGerhard LohrmannThomas Werner
    • Gunther EngelhardtGerhard LohrmannThomas Werner
    • B41J13/00B41J13/10B65H29/60B65H31/06
    • B41J13/10B41J13/103B41J13/106
    • A paper stacking apparatus is for an office machine, wherein the office machine has a forward end and a rear end and includes rollers for sequentially supplying sheets of paper upwardly along a generally vertical path. The sheets extend transversely of the office machine. The path is located between the front end and the rear end. The paper stacking apparatus includes a support frame located above the rollers for sequentially supplying said sheets. A paper guide element is mounted within the support frame in alignment with the path. A forward stacker is mounted on the support frame forwardly of the paper guide element. A rear stacker is mounted on the support frame rearwardly of the paper guide element. The paper guide element is selectively movable to a forward position and to a rear position. The paper guide element at the forward position directs the sheets to the forward stacker for forward to rear stacking of the sheets thereon. The paper guide element at the rear position directs the sheets to the rear stacker for rear to forward stacking of the sheets thereon.
    • 纸张堆叠装置用于办公机器,其中办公机器具有前端和后端,并且包括用于沿着大致垂直的路径向上顺序地供应纸张的辊。 纸张横向延伸在办公室机器上。 路径位于前端和后端之间。 纸张堆垛装置包括位于辊子上方的用于顺序地供应所述片材的支撑框架。 纸张引导元件安装在支撑框架内,与路径对齐。 向前堆垛机被安装在纸引导元件前方的支撑框架上。 后堆垛机安装在纸引导元件后方的支撑框架上。 纸张引导元件可选择性地移动到前进位置和后方位置。 纸张引导元件在前方位置将纸张引导到向前堆垛机,以便在纸张的前后堆叠。 后方的导纸元件将纸张引导到后堆垛机后方,以便将纸张在其上进行堆叠。
    • 29. 发明授权
    • Esters and amides containing the
1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetyl moiety
    • 含有1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-乙酰基部分的酯和酰胺
    • US4362738A
    • 1982-12-07
    • US158587
    • 1980-06-11
    • Johannes KeckGerd KrugerHelmut PieperKlaus NollGunther EngelhardtNorbert PrombergerRainer Zimmermann
    • Johannes KeckGerd KrugerHelmut PieperKlaus NollGunther EngelhardtNorbert PrombergerRainer Zimmermann
    • C07D209/08A61K31/495A61P29/00C07C67/00C07C227/00C07C227/16C07C227/18C07C229/54C07C237/32C07C237/38C07C313/00C07C323/12C07C323/65C07D209/28C07D213/74C07D295/088C07D295/155C07D401/12C07H13/08C07D279/18A61K27/00
    • C07D213/74C07D209/28C07D295/088C07D295/155
    • Compounds of the formula ##STR1## wherein each X, which may be identical or different from the other X, is oxygen or imino;R.sub.1 is hydrogen, fluorine, chlorine or bromine;R.sub.2 and R.sub.3, which may be identical or different from each other, are each hydrogen; unsubstituted or mono-substituted alkyl of 1 to 6 carbon atoms, where the substituent is phenyl or dialkylamino with 1 to 3 carbon atoms in each alkyl moiety; pyridyl; or cycloalkyl of 5 to 7 carbon atoms;R.sub.2 and R.sub.3, together with each other and the nitrogen atoms to which they are attached, are pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-aryl-piperazino or N-(alkyl of 1 to 3 carbon atoms)-piperazino;A is cycloalkylene of 5 to 7 carbon atoms; unsubstituted or substituted alkylene of 2 to 10 carbon atoms, where the substituents are one to two alkyls of 1 to 3 carbon atoms each, one to two carbalkoxys of 2 to 4 carbon atoms each, one to two phenyls, one to four hydroxyls, one halomethyl, one hydroxymethyl, one alkanoyloxy of 1 to 18 carbon atoms, one alkanoyloxymethyl of 1 to 18 carbon atoms in the alkanoyl moiety or one ##STR2## where R.sub.1, R.sub.2 and R.sub.3 have the meanings previously defined; or alkylene of 2 to 10 carbon atoms interrupted by oxygen, sulfur, sulfoxide, sulfonyl, phenyl, cyclohexyl, pyridyl, piperazino or unsubstituted or substituted imino, where the substituent on the imino group is alkyl of 1 to 6 carbon atoms, phenyl or phenylalkyl of 1 to 3 carbon atoms in the alkyl moiety;B is the acyl residue of an antiphlogistic carboxylic acid;and their non-toxic, pharmacologically acceptable acid addition salts. The compounds as well as their salts are useful as anti-inflammatories.
    • 其中每个X可以相同或不同于另一个X的式“IMAGE”的化合物是氧或亚氨基; R1是氢,氟,氯或溴; R2和R3可以相同或不同,分别为氢; 未取代或单取代的1至6个碳原子的烷基,其中取代基为苯基或每个烷基部分具有1至3个碳原子的二烷基氨基; 吡啶基 或5至7个碳原子的环烷基; 吡咯烷基,哌啶子基,六亚甲基亚氨基,吗啉代,N-芳基 - 哌嗪子基或N-(1至3个碳原子的烷基) - 哌嗪基; R 2和R 3彼此连接并连接的氮原子。 A是5至7个碳原子的亚环烷基; 2至10个碳原子的未取代或取代的亚烷基,其中取代基为1至2个碳原子数为1至2个的烷基,每个为2至4个碳原子的1至2个碳烷氧基,1至2个苯基,1至4个羟基,1至2个 卤代甲基,一个羟甲基,一个1至18个碳原子的烷酰氧基,一个在烷酰基部分中具有1至18个碳原子的烷酰氧基甲基或一个,其中R1,R2和R3具有以前定义的含义; 或由氧,硫,亚砜,磺酰基,苯基,环己基,吡啶基,哌嗪子基或未取代或取代的亚氨基所取代的2至10个碳原子的亚烷基,其中亚氨基上的取代基是1至6个碳原子的烷基,苯基或苯基烷基 在烷基部分中具有1至3个碳原子; B是消炎性羧酸的酰基残基; 及其无毒,药理学上可接受的酸加成盐。 化合物及其盐可用作抗炎剂。